title: Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.
abstract: Clinical investigators in oncology are increasingly interested in using molecular analysis of cancer tissue to understand the biologic bases of response or resistance to novel interventions and to develop prognostic and predictive biomarkers that will guide clinical decision making. Some scientific questions of this nature can only be addressed, or may best be addressed, through the conduct of a clinical trial in which research biopsies are obtained from all participants. However, trial designs with mandatory research biopsies have raised ethical concerns related to the risk of harm to participants, the adequacy of voluntary informed consent, and the potential for misunderstanding among research participants when access to an experimental intervention is linked to the requirement to undergo a research biopsy. In consideration of the ethical and scientific issues at stake in this debate, the Cancer and Leukemia Group B Ethics Committee proposes guidelines for clinical trials involving mandatory research biopsies. Any cancer clinical trial that requires research biopsies of participants must be well designed to address the scientific question, obtain the biopsy in a way that minimizes risk, and ensure that research participants are fully informed of the risks, rationale, and requirements of the study, as well as of treatment alternatives. Further guidelines and discussions of this issue are specified in this position paper. We feel that if these principles are respected, an informed adult with cancer can both understand and voluntarily consent to participation in a clinical trial involving mandatory research biopsy for scientific end points.
authors.affiliation: Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA. jeffrey.peppercorn@duke.edu
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Peppercorn
authors.forename: Iuliana
authors.initials: I
authors.lastname: Shapira
authors.forename: Deborah
authors.initials: D
authors.lastname: Collyar
authors.forename: Teresa
authors.initials: T
authors.lastname: Deshields
authors.forename: Nancy
authors.initials: N
authors.lastname: Lin
authors.forename: Ian
authors.initials: I
authors.lastname: Krop
authors.forename: Hans
authors.initials: H
authors.lastname: Grunwald
authors.forename: Paula
authors.initials: P
authors.lastname: Friedman
authors.forename: Ann H
authors.initials: AH
authors.lastname: Partridge
authors.forename: Richard L
authors.initials: RL
authors.lastname: Schilsky
authors.forename: Monica M
authors.initials: MM
authors.lastname: Bertagnolli
mesh_terms: D000328:Adult; D001706:Biopsy / Q000941:ethics* / Q000379:methods; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000379:methods; D023381:Endpoint Determination / Q000941:ethics / Q000379:methods; D006801:Humans; D018580:Mandatory Testing / Q000941:ethics* / Q000379:methods; D008495:Medical Oncology / Q000941:ethics* / Q000379:methods
references.citation: Eur Respir J. 2004 Sep;24(3):375-7
references.pmid: 15358694
references.citation: J Clin Oncol. 2004 Dec 1;22(23):4846-50
references.pmid: 15570088
references.citation: Breast Cancer Res Treat. 2009 Jan;113(2):207-9
references.pmid: 18463974
references.citation: J Clin Oncol. 2006 Oct 20;24(30):4793-5
references.pmid: 17050863
references.citation: J Clin Oncol. 1995 May;13(5):1062-72
references.pmid: 7738612
references.citation: JAMA. 2000 May 24-31;283(20):2701-11
references.pmid: 10819955
references.citation: Lancet. 2000 Aug 19;356(9230):635-8
references.pmid: 10968436
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5
references.pmid: 18765795
references.citation: N Engl J Med. 2009 May 14;360(20):2055-65
references.pmid: 19439741
references.citation: Clin Cancer Res. 2001 Oct;7(10):2971-6
references.pmid: 11595684
references.citation: Clin Cancer Res. 2008 Apr 15;14(8):2512; author reply 2513-4
references.pmid: 18413847
references.citation: J Natl Cancer Inst. 1988 Aug 17;80(12):886-7
references.pmid: 3398065
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: J Clin Oncol. 2008 Aug 20;26(24):3987-94
references.pmid: 18711189
references.citation: Cancer J. 2002 Nov-Dec;8(6):461-8
references.pmid: 12500855
references.citation: N Engl J Med. 2008 Oct 23;359(17):1757-65
references.pmid: 18946061
references.citation: J Clin Oncol. 2008 Nov 20;26(33):5352-9
references.pmid: 18955458
references.citation: J Natl Cancer Inst. 2001 Jan 17;93(2):139-47
references.pmid: 11208884
references.citation: J Clin Oncol. 2008 Oct 1;26(28):4679-83
references.pmid: 18662965
references.citation: Cancer Cell. 2007 Oct;12(4):395-402
references.pmid: 17936563
references.citation: Annu Rev Med. 2008;59:429-42
references.pmid: 17716025
references.citation: Clin Trials. 2011 Oct;8(5):616-23
references.pmid: 21813584
references.citation: J Urol. 2006 May;175(5):1605-12
references.pmid: 16600713
references.citation: Ann Hematol. 2007 Feb;86(2):117-25
references.pmid: 17031690
references.citation: J Clin Oncol. 2007 Jul 20;25(21):3069-75
references.pmid: 17634485
references.citation: Gastrointest Endosc. 2009 Apr;69(4):906-10
references.pmid: 19136110
references.citation: Br J Cancer. 2005 Mar 28;92(6):1001-5
references.pmid: 15770219
references.citation: J Clin Oncol. 2008 Sep 10;26(26):4311-8
references.pmid: 18779618
references.citation: J Clin Oncol. 2009 Apr 20;27(12):2091-6
references.pmid: 19188670
references.citation: J Clin Oncol. 2007 Jul 1;25(19):2741-6
references.pmid: 17602079
references.citation: PLoS Med. 2007 Nov 27;4(11):e324
references.pmid: 18044980
references.citation: PLoS One. 2006 Dec 20;1:e98
references.pmid: 17183730
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: J Clin Oncol. 2009 Aug 20;27(24):4027-34
references.pmid: 19597023
references.citation: N Engl J Med. 2003 Mar 13;348(11):994-1004
references.pmid: 12637609
references.citation: J Natl Compr Canc Netw. 2009 Jul;7 Suppl 4:S1-34, quiz S35-6
references.pmid: 19635230
references.citation: J Clin Oncol. 2004 Nov 1;22(21):4312-8
references.pmid: 15514372
references.citation: Science. 2004 Jan 16;303(5656):333
references.pmid: 14726584
references.citation: N Engl J Med. 2004 May 20;350(21):2129-39
references.pmid: 15118073
references.citation: J Clin Oncol. 2007 Apr 10;25(11):1454-5
references.pmid: 17416872
references.citation: J Am Coll Dent. 2014 Summer;81(3):4-13
references.pmid: 25951677
references.citation: Prostate. 2007 May 1;67(6):603-4
references.pmid: 17290443
references.citation: Cancer Invest. 2008 Feb;26(1):1-10
references.pmid: 18181038
references.citation: J Clin Oncol. 2006 Oct 20;24(30):4801-7
references.pmid: 17050865